VintaBio Seeks Bids for Philadelphia Facility
The viral vector manufacturer's assignee is selling its Philadelphia cGMP facility, equipment and intellectual property after a creditor assignment.
Philadelphia Biotech News
This page covers biotech in Philadelphia, from drug development and gene therapy to clinical trials, funding and acquisitions. Reporting follows the research institutions, companies and regulatory milestones that shape the field in the region.
Recent news
November 4, 2026
Penn-BioNTech Fund Backs Emvena TherapeuticsThe PxB Fund, a $50 million venture fund, made its first investment in Emvena, a startup developing placenta-targeted mRNA medicines for preeclampsia.
November 3, 2026
Penn Team Eyes CRISPR to Slow Muscular DystrophyResearchers in Philadelphia report a preclinical approach that boosts a stand-in protein, alongside a personalized gene-editing treatment for a rare infant disorder.
October 25, 2026
Philadelphia Biotech Firm to Present Gene Therapy ResearchLatus Bio will unveil four preclinical research posters at an annual gene therapy conference in Germany later this month.
October 20, 2026
Century Therapeutics to Meet Investors November 18The Philadelphia biotech firm will discuss its cell therapy pipeline at the upcoming Jefferies Global Healthcare Conference.
October 14, 2026
Cabaletta Bio Granted Stock Options to New EmployeesThe Philadelphia-based biotech firm issued 385,000 shares to four recent hires as an inducement for employment.
October 13, 2026
Latus Bio Developed Kidney Gene-Delivery TechnologyThe Philadelphia-based company engineered a viral capsid that achieved significantly improved tissue targeting in primates.
September 29, 2026
Aro Biotherapeutics Appointed Brett Blackman to BoardThe Philadelphia-based biotech company added the veteran executive to its leadership team to support growth.
September 28, 2026
Tolerance Bio Licensed Anti-IL-33 Drug From Tanabe PharmaThe Philadelphia-based company secured global rights, excluding Japan, to advance the drug toward Phase 2 trials.
September 23, 2026
Pharma Leaders Gathered in PhiladelphiaThe event drew over 3,500 industry professionals to the Pennsylvania Convention Center for a four-day conference.
September 19, 2026
Latus Bio Appointed New Board MembersThe Philadelphia-based biotech firm added two experienced executives to help oversee its transition to clinical-stage work.
Regular subjects here include clinical trial results, gene therapy and gene editing approvals, biotech financings and public offerings, and mergers that move research programs between companies. Coverage reaches the city's research campuses and the life sciences companies around them, across the city and the surrounding region. The region's dense cluster of research institutions makes academic discoveries a frequent starting point for commercial stories. Long development timelines and the cost of trials remain the constraints that most often decide which programs advance.